Uvax Bio

Website

Operator of a biotechnology company intended to create nanoparticle vaccine through antigen design. The company's platform develops and commercializes B-cell-focused, rapid antibody-eliciting vaccines...

Healthcare
Newark, DE, United States
Founded 2018
14 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$23.6M
Last Round
N/A
Investors
+2 other investors
View all 2 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Uvax Bio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required